FdaApplication
BLA 761134
Identifiers
- fda_app_no: BLA761134
Properties
| Property | Value |
|---|---|
| applicant_name | Evive Biotechnology Singapore PTE. LTD. |
| application_type | BLA |
| approval_date | 2023-11-16 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RYZNEUTA | EFBEMALENOGRASTIM ALFA-VUXW | 20MG/ML | Injection |
1 product